Viemed Healthcare, Inc.
VMD- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001729149
No open-market purchases or sales by Viemed Healthcare, Inc. insiders were filed in the last 90 days; 166 institutions reported holding it in 13F filings for Q2 2026, worth $291.2M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Viemed Healthcare, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +15 vs. Q1 2023
- Shares held
- 24.3M
- +1.95M (+8.7%) vs. Q1 2023
- Total value
- $246.4M
- +$29.0M (+13.3%) vs. Q1 2023
- New holders
- 32
- 26 more added
- Sold out
- 17
- 31 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 166 | $291.2M |
| Q1 2026 | 150 | $229.2M |
| Q4 2025 | 132 | $177.0M |
| Q3 2025 | 131 | $166.2M |
| Q2 2025 | 127 | $175.5M |
| Q1 2025 | 139 | $180.9M |
| Q4 2024 | 141 | $201.7M |
| Q3 2024 | 121 | $185.5M |
| Q2 2024 | 116 | $166.5M |
| Q1 2024 | 112 | $233.4M |
| Q4 2023 | 104 | $181.9M |
| Q3 2023 | 112 | $158.7M |
| Q2 2023 | 103 | $246.4M |
| Q1 2023 | 89 | $217.5M |
| Q4 2022 | 81 | $152.3M |
| Q3 2022 | 65 | $110.0M |
| Q2 2022 | 76 | $104.5M |
| Q1 2022 | 89 | $109.4M |
| Q4 2021 | 89 | $116.8M |
| Q3 2021 | 83 | $119.1M |
| Q2 2021 | 77 | $161.1M |
| Q1 2021 | 100 | $214.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Viemed Healthcare, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,913,664 | $18.7M | 0.00% | +1,428,667+294.6% | Added |
| Forager Capital Management, LLC | 1,935,191 | $25.1M | 8.37% | −64,455−3.2% | Reduced |
| Thrivent Financial for Lutherans | 3,511,381 | $34.3M | 0.08% | −1,093,827−23.8% | Reduced |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −101,882−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −81,385−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −80,291−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −55,673−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −24,095−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −19,905−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −18,534−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −15,929−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,861−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,486−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −13,251−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −12,910−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −4,941−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,542−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,684−100.0% | Sold out |
| Ahrens Investment Partners LLC | – | – | – | – | Not filed |